Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription

Advances in Virus Research

Volumn 46, Issue , 1996, Pages 97-163

  Arts, E J ^a   Wainberg, M A ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030047819     PISSN: 00653527     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0065-3527(08)60071-8     Document Type: Review

References (333)

1. J. Abbotts K. Bebenek T.A. Kunkel S.H. Wilson Mechanism of HIV-1 reverse transcriptase: Termination of processive synthesis on a natural DNA template is influenced by the sequence of the template–primer stem. J. Biol. Chem. 268 1993 10312 10323
2. Trp primer is required for efficient initiation of reverse transcription. J. Virol. 66 1992 2464 2472
3. A. Aiyar Z. Ge J. Leis A specific orientation of RNA secondary structures is required for initiation of reverse transcription. J. Virol. 68 1994 611 168
4. B. Allain M. Lapadat-Tapolsky C. Berlioz J.-L. Darlix Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome. EMBO J. 13 1994 973 981
5. lys with the p66/p66 form of HIV-1 reverse transcriptase stimulates DNA polymerase and ribonuclease H activities. J. Biol. Chem. 267 1992 19356 19362
6. M.-L. Andreola L. Tarrago-Litvak A.S. Levina T.I. Kolocheva R. El Dirani-Diab Affinity labeling and functional analysis of the primer binding domain of HIV-1 reverse transcriptase. Biochemistr. 32 1993 3629 3637
7. P. Argos A sequence motif in many polymerases. Nucleic Acids Res. 16 1988 9909 9916
8. E. Arnold A. Jacobo-Molina R.G. Nanni R.L. Williams X. Lu Structure of HIV-1 reverse transcriptase/DNA complex at 7 Å resolution showing active site locations. Nature (London. 357 1992 85 89
9. E.J. Arts M.A. Weinberg Preferential incorporation of nucleoside analogs after the first template switch during human immunodeficiency virus reverse transcription. Antimicrob. Agents Chemother. 38 1994 1008 1016
10. E.J. Arts J. Mak L. Kleiman M.A. Weinberg DNA found in human immunodeficiency virus type 1 particles may not be required for infectivity. J. Gen. Virol. 75 1994 1605 1613
11. Lys3 as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template switching assay. J. Biol. Chem. 269 1994 14672 14680
12. S.K. Arya C. Guo S.F. Josephs F. Wong-Staal Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Scienc. 229 1985 69 73
13. A. Bacolla C.K. Shih J.M. Rose G. Piras T.C. Warren Amino acid substitutions in HIV-1 reverse transcriptase with corresponding residues from HIV-2. Effect on kinetic constants and inhibition by non-nucleoside analogs. J. Biol. Chem. 268 1993 16571 16577
14. M. Bakhanashvili A. Hizi Fidelity of the RNA-dependent DNA synthesis exhibited by the reverse transcriptases of human immunodeficiency virus types 1 and 2 and of murine leukemia virus: Mispair extension frequencies. Biochemistr. 31 1992 9393 9398
15. M. Bakhanashvili A. Hizi The fidelity of the reverse transcriptases of human immunodeficiency viruses and murine leukemia virus, exhibited by the mispair extension frequencies is sequence dependent and enzyme related. FEBS Lett. 319 1993 201 205
16. M. Bakhanashvili A. Hizi Interaction of the reverse transcriptase of human immunodeficiency virus type 1 with DNA. Biochemistr. 33 1994 12222 12228
17. D. Baltimore RNA-dependent DNA polymerase in virions of RNA tumor viruses. Nature (London. 226 1970 1209 1211
18. C. Barat V. Lullien O. Schatz G. Keith M.T. Nugeyre F. Gruninger-Leitch F. Barre-Sinoussi S.F.J. Le Grice J.L. Darlix HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. EMBO J. 8 1989 3279 3285
19. C. Barat S.F.J. Le Grice J.L. Darlix Interaction of HIV-1 reverse transcriptase with a synthetic form of its replication primer. Nucleic Acids Res. 19 1991 751 757
20. C. Barat O. Schatz S. Le Grice J.L. Darlix Analysis of the interactions of HIV-1 replication primer tRNA( Lys3 ) with nucleocapsid protein and reverse transcriptase. J. Mol. Biol. 231 1993 185 190
21. P.J. Barr M.D. Power C.T. Lee-Ng H.L. Gibson P.A. Luciw Expression of active human immunodeficiency virus reverse transcriptase in Saccharomyces cerevisiae. Bio/Technology 5 1987 486 489
22. F. Barre-Sinoussi J.C. Chermann F. Rey M.T. Nugeybe S. Chamaret Isolation of a T-lymphocyte retrovirus from a patient at risk of acquired immune deficiency syndrome (AIDS). Scienc. 220 1983 868 870
23. A. Basu R.S. Tirumalai M.J. Modak Substrate binding in human immunodeficiency virus reverse transcriptase. An analysis of pyridoxal 5′-phosphate sensitivity and identification of lysine 263 in the substrate-binding domain. J. Biol. Chem. 264 1989 8746 8752
24. A. Basu S. Basu M.J. Modak Structure–activity analyses of HIV-1 reverse transcriptase. Biochem. Biophys. Res. Commun. 183 1993 1131 1138
25. F. Baudin R. Marquet C. Isel J.L. Darlix B. Ehresmann C. Ehresmann Functional sites in the 5′ region of human immunodeficiency virus type1 RNA form defined structural domains. J. Mol. Biol. 229 1993 382 397
26. M.R. Bavand R. Wagner M.J. Richmond HIV-1 reverse transcriptase: Polymerization properties of the p51 homodimer compared to the p66/p51 heterodimer. Biochemistr. 32 1993 10543 10552
27. W.A. Beard S.J. Stahl H.-R. Kim K. Bebenek A. Kumar M.-P. Strub S.P. Becerra T.A. Kunkel S.H. Wilson Structure/function studies of human immunodeficiency virus type 1 reverse transcriptase. Alanine scanning mutagenesis of an α-helix in the thumb subdomain. J. Biol. Chem. 269 1994 28091 28097
28. K. Bebenek J. Abbotts J.D. Roberts S.H. Wilson T.A. Kunkel Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase. J. Biol. Chem. 264 1989 16948 16956
29. K. Bebenek J.D. Roberts T.A. Kunkel The effects of dNTP pool imbalances on frameshift fidelity during DNA replication. J. Biol. Chem. 267 1992 3589 3596
30. K. Bebenek J. Abbotts S.H. Wilson T.A. Kunkel Error-prone polymerization by HIV-1 reverse transcriptase: Contribution of template-primer misalignment, miscoding and termination probability to mutational hot spots. J. Biol. Chem. 268 1993 10324 10334
31. S.P. Becerra G.M. Clore A.M. Gronenborn A.R. Karlstrom S.J. Stahl Purification and characterization of the RNase H domain of HIV-1 reverse transcriptase expressed in recombinant Escherichia coli. FEBS Lett. 270 1990 76 80
32. S.P. Becerra A. Kumar M.S. Lewis S.G. Widen J. Abbotts E.M. Karawya S.H. Hughes J. Shiloach S.H. Wilson Protein–protein interactions of HIV-1 reverse transcriptase: Implications of central and C-terminal regions in subunit binding. Biochemistr. 30 1991 11707 11719
33. L.S. Beese T.A. Steitz Structural basis for the 3′-5′ exonuclease activity of Escherichia coli DNA polymerase I: A metal ion mechanism. EMBO J. 10 1991 25 33
34. H. Ben-Artzi E. Zeelon M. Gorecki A. Panet Double-stranded RNA-dependent RNase activity associated with human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl. Acad. Sci. U.S.A. 89 1992 927 931
35. H. Ben-Artzi E. Zeelon S.F.J. Le Grice M. Gorecki A. Panet Characterization of the double stranded RNA dependent RNase activity associated with recombinant reverse transcriptases. Nucleic Acids Res. 20 1992 5115 5118
36. H. Ben-Artzi E. Zeelon B. Amit A. Wortzel M. Gorecki A. Panet RNase H activity of reverse transcriptases on substrates derived from the 5′ end of retroviral genome. J. Biol. Chem. 268 1993 16465 16471
37. B. Berkhout I. Schoneveld Secondary structure of the HIV-2 leader RNA comprising the tRNA-primer binding site. Nucleic Acids Res. 21 1993 1171 1178
38. R.D. Berkowitz J. Luban S.P. Goff Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays. J. Virol. 67 1993 7190 7200
39. N. Biswal B. Mc Cain M. Bensyesh-Melnick The DNA of murine sarcoma-leukemia virus. Virolog. 45 1971 697 706
40. J.D. Boeke D.J. Garfinkel C.A. Styles G.R. Fink Ty elements transpose through an RNA intermediate. Cell (Cambridge, Mass.) 40 1985 491 500
41. Lys. Nucleic Acids Res. 18 1990 429 436
42. K. Borroto-Esoda L.R. Boone Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro : Characterization of the endogenous reverse transcriptase reaction. J. Virol. 65 1991 1952 1959
43. M.L. Boshl P.L. Earl K. Fargnoli S. Picciafuoco F. Giombini Identification of the fusion peptide of primate immunodeficiency virus. Scienc. 244 1989 694 697
44. P.L. Boyer A.L. Ferris S.H. Hughes Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1. J. Virol. 66 1992 1031 1039
45. P.L. Boyer A.L. Ferris S.H. Hughes Mutational analysis of the fingers domain of human immunodeficiency virus type 1 reverse transcriptase. J. Virol. 66 1992 7533 7537
46. P.L. Boyer A.L. Ferris P. Clark J. Whitmer P. Frank C. Tantillo E. Arnold S.H. Hughes Mutational analysis of the fingers and palm subdomains of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase. J. Mol. Biol. 243 1994 472 483
47. M.I. Bukrinsky S. Haggerty M.P. Dempsey N. Sharova A. Adzhubel A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature (London. 365 1993 666 669
48. M. Bukrinsky N. Sharova M. Stevenson Human immunodeficiency virus type 1 2-LTR circles reside in a nucleoprotein complex which is different from the preintegration complex. J. Virol. 67 1993 6863 6865
49. F.D. Bushman T. Fujiwara R. Craigie Retroviral DNA integration directed by HIV integration protein in vitro. Science 249 1990 1555 1558
50. H. Cai L.B. Bloom R. Eritja M.F. Goodman Kinetic of deoxyribo-nucleotide insertion and extension at abasic template lesions in different sequence contexts using HIV-1 reverse transcriptase. J. Biol. Chem. 268 1993 23567 23572
51. J.J. Champoux E. Gilboa D. Baltimore Mechanism of RNA primer removal by RNase H activity of avian myeloblastosis virus reverse transcriptase. J. Virol. 49 1984 686 691
52. D.D. Chang P.A. Sharp Regulation by HIV rev depends upon recognition of splice sites. Cell (Cambridge, Mass.) 59 1989 789 795
53. M. Chastain I. Tinoco Jr. Structural elements in RNA. Prog. Nucleic Acid Res. Mol. Biol. 41 1991 131 177
54. D. Chattopadhyay D.B. Evans M.R. Deibel Jr. A.F. Voster F.M. Eckenrode Purification and characterization of heterodimeric human immunodeficiency virus type 1 (HIV-1) reverse transcriptase produced by in vitro processing of p66 with recombinant HIV-1 protease. J. Biol. Chem. 267 1992 14227 14232
55. W.P. Cheevers T.C. Mc Guire Equine infectious anemia virus: Immunopathogenesis and persistence. Rev. Infect. Dis. 7 1985 83 88
56. N. Cheng G.R. Painter P.A. Furman Cross-linking of substrates occurs exclusively to the p66 subunit of heterodimeric HIV-1 reverse transcriptase. Biochem. Biophys. Res. Commun. 174 1991 785 789
57. N. Cheng B.M. Merril G.R. Painter L.W. Frick P.A. Furman Identification of the nucleotide binding site of HIV-1 reverse transcriptase using dTTP as a photoaffinity label. Biochemistr. 32 1993 7630 7634
58. Y.-C. Cheng G.E. Dutchman M.K. Bastow M.G. Sarngadharan R.Y.C. Ting Human immunodeficiency virus reverse transcriptase: General properties and its interaction with nucleoside triphosphate analogs. J. Biol. Chem. 262 1987 2187 2189
59. N.M. Cirino R.C. Kalayjian J.E. Jentoff S.F.J. Le Grice Fluorimetric analysis of recombinant p15 HIV-1 ribonuclease H. J. Biol. Chem. 268 1993 14743 14749
60. D. Cobrinik R. Katz R. Terry A.M. Skalka J. Leis Avian sarcoma and leukosis virus pol -endonuclease recognition of the tandem long terminal repeat junction: Minimum site required for cleavage is also required for viral growth. J. Viro. 61 1987 1999 2008
61. D. Cobrinik L. Saskey J. Leis A retroviral secondary structure required for efficient initiation for reverse transcription. J. Viro. 62 1988 3622 3630
62. D. Cobrinik A. Aiyar Z. Ge M. Katzman H. Huang J. Leis Overlapping U5 sequence elements are required for efficient integration and initiation of reverse transcription. J. Virol. 65 1991 3864 3872
63. M.S. Collett J.P. Leis M.S. Smith A.J. Faras Unwinding-like activity associated with retrovirus RNA-directed DNA polymerase. J. Virol. 65 1978 6961 6968
64. R.C. Craven R.P. Burnet J.W. Wills Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly. J. Virol. 65 1992 6205 6217
65. D. Crother DNA bends and bendability. Y. Kyogoku Y. Nishimura ‘Molecular Structure and Life’ 1992 Japan Science Society Press, Tokyo/CRC Press Boca Raton, Florida 67 77
66. B.R. Cullen Regulation of human immunodeficiency virus replication. Annu. Rev. Microb. 45 1991 219 250
67. J.E. Dahlberg R.C. Saywer J.M. Taylor A.J. Faras W.E. Levinson Transcription of DNA from the 70S RNA of Rous sarcoma virus. I. Identification of a specific 4S RNA which serves as primer. J. Virol. 13 1974 1126 1133
68. J.L. Darlix C. Gabus M.T. Nugeyre F. Clavel F. Barre-Sinoussi Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J. Mol. Biol. 216 1990 689 699
69. J.F. Davies II Z. Hostomska Z. Hostomsky S.R. Jordan D.A. Matthews Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase. Scienc. 252 1991 88 95
70. J.L. Davis S. Molineaux J.E. Clements Visna virus exhibits a complex transcriptional pattern: One aspect of gene expression shared with acquired immunodeficiency syndrome retrovirus. J. Virol. 61 1987 1325 1331
71. H. De Rocquigny C. Gabus A. Vincent M.C. Fournie-Zaluski B. Roques J.L. Darlix Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl. Acad. Sci. U.S.A. 89 1992 6472 6476
72. J.J. De Stefano R.G. Buiser L.M. Mallaber T.W. Myers R.A. Bambara P.J. Fay Polymerization and RNase H activities of the reverse transcriptases from avian myeloblastosis, human immunodeficiency, and Moloney murine leukemia viruses are functionally uncoupled. J. Biol. Chem. 266 1991 7423 7431
73. J.J. De Stefano L.M. Mallaber L. Rodriguez-Rodriguez P.J. Fay R.A. Bambara Requirements for strand transfer between internal regions of heteropolymer templates by human immunodeficiency virus reverse transcriptase. J. Virol. 66 1992 6370 6378
74. J.J. De Stefano L.M. Mallaber P.J. Fay R.A. Bambara Quantitative analysis of RNA cleavage during DNA synthesis by human immunodeficiency and avian myeloblastosis virus reverse transcriptases. Nucleic Acids Res. 22 1994 3793 3800
75. A. Dhundale T. Furuichi S. Inouye M. Inouye Structure of msDNA from Myxococcus xanthus : Evidence for a long, self-annealing RNA precursor for the covalently linked, branched RNA. Cell (Cambridge, Mass.) 51 1987 1105 1112
76. F. Dib-Hajj R. Khan D.P. Giedroc Retroviral nucleocapsid proteins possess potent nucleic acid strand renaturation activity. Protein Sci. 2 1993 231 243
77. F. Di Marzo Veronese T.D. Copeland A.L. De Vico R. Rahman S. Oroszlan Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Scienc. 231 1986 1289 1291
78. G. Divita T. Restle R.S. Goody J.-C. Chermann J.G. Baillon Inhibition of human immunodeficiency virus type 1 reverse transcriptase dimerization using synthetic peptides derived from the connection domain. J. Biol. Chem. 269 1994 13080 13083
79. P.R. Donahue E.A. Hoover G.A. Beltz N. Riedel V.M. Hirsh Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J. Virol. 62 1988 722 731
80. P.L. Earl B. Moss R.W. Doms Folding, interaction with GRP-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. J. Virol. 65 1991 2047 2055
81. A. Engelman K. Mizuuchi R. Craigie HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer. Cell (Cambridge, Mass.) 67 1991 1211 1221
82. E. Erikson R.L. Erikson Association of 4S RNA with oncornavirus RNA. J. Virol. 8 1971 254 256
83. D.B. Evans K. Brawn M.R. Deibel Jr. W.G. Tarpley S.K. Sharma A recombinant ribonuclease H domain of HIV-1 reverse transcriptase that is enzymatically active. J. Biol. Chem. 266 1991 20583 20585
84. D.B. Evans N. Fan S.M. Swaney W.G. Tarpley S.K. Sharma An active recombinant p15 RNase H domain is functionally distinct from the RNase H domain associated with human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem. 269 1994 21741 21747
85. M. Fache A. Janetzko R.L. Shoeman H.G. Krausslich A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J. Virol. 67 1993 4972 4980
86. A.J. Faras A.C. Garapin W.E. Levinson J.M. Bishop J.M. Goodman Characterization of the low-molecular-weight RNAs associated with the 70S RNA of Rous sarcoma virus. J. Virol. 12 1973 334 342
87. W.G. Farmerie D.D. Loeb N.C. Casavant C.A. Hutchison III M.A. Edgell R. Swanstrom Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli. Science 236 1987 305 308
88. O.Y. Federoff M. Salazar B.R. Reid Structure of a DNA:RNA hybrid duplex. Why RNase H does not cleave pure RNA. J. Mol. Biol. 233 1993 509 523
89. P.M. Fitzgerald B.M. Mc Keever J.F. van Middlesworth J.P. Singer J.C. Heimbach Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-Å resolution. J. Biol. Chem. 265 1990 14209 14219
90. J.E. Fitzgibbon R.M. Howell C.A. Haberzettl S.J. Sperber D.J. Gocke D.T. Dubin Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2′,3′-dideoxycytidine. Antimicrob. Agents Chemother. 36 1992 153 157
91. T.-B. Fu J. Taylor When retroviral reverse transcriptase reach the end of their RNA templates. J. Virol. 66 1992 4271 4278
92. W. Fu A. Rein Maturation of dimeric viral RNA of Moloney murine leukemia virus. J. Virol. 67 1993 5443 5449
93. E.S. Furfine J.E. Reardon Reverse transcriptase-RNase H from the human immunodeficiency virus: Relationship of the DNA polymerase and RNA hydrolysis activities. J. Biol. Chem. 266 1991 406 412
94. P.A. Furman G. Painter J.E. Wilson N. Cheng S. Hopkins Substrate inhibition of the human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl. Acad. Sci. U.S.A. 88 1991 6013 6017
95. D. Ganem H.E. Varmus The molecular biology of the hepatitis B virus. Annu. Rev. Biochem. 56 1987 651 693
96. Q. Gao X. Gu J.M. Cameron N. Cammack C. Boucher M.A. Wainberg The same mutation that encodes low-level HIV-1 resistance to 2′,3′-dideoxycytidine confers high level resistance against the (–) enantiomer of 2′,3′-dideoxy-3′-thiacytidine (3TC). Antimicrob. Agents Chemother. 37 1993 1390 1392
97. R. Geleziunas E.J. Arts F. Boulerice H. Goldman M.A. Wainberg Effect of 3′-azido-3′-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages. Antimicrob. Agents Chemother. 37 1993 1305 1319
98. M. Ghosh K.J. Howard C.E. Cameron S.J. Benkovic S.H. Hughes S.F.J. Le Grice Truncating a-helix E' of p66 human immunodeficiency virus reverse transcriptase modulates RNase H function and impairs DNA strand transfer. J. Biol. Chem. 270 1995 7068 7076
99. E. Gilboa S.W. Mitra S.P. Goff D. Baltimore A detailed model of reverse transcription and tests of crucial aspects. Cell (Cambridge, Mass.) 18 1979 93 100
100. V. Gopalakrishnan J.A. Peliska S.J. Benkovic Human immunodeficiency virus type 1 reverse transcriptase: Spatial and temporal relationship between the polymerase and RNase H activities. Proc. Natl. Acad. Sci. U.S.A. 89 1992 10763 10767
101. M.S. Gottlieb R. Schroff H.M. Schanler J.D. Weisman P.T. Fan Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immuno-deficiency. N Engl. J. Med. 305 1981 1426 1431
102. H.G. Gottlinger J.G. Sodroski W.A. Hasseltine Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 86 1989 5781 5785
103. H.G. Gottlinger T. Dorfman E.A. Cohen W.A. Haseltine vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. U.S.A. 90 1993 7381 7385
104. C.W. Greider E.H. Blackburn Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell (Cambridge, Mass.) 43 1985 405 413
105. Z. Gu Q. Gao X. Li M.A. Parniak M.A. Wainberg Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene encodes cross-resistance to 2′,3′-dideoxyinosine and 2′,3′-dideoxycytidine. J. Virol. 66 1992 7128 7135
106. Z. Gu R.S. Fletcher E.J. Arts M.A. Wainberg M.A. Parniak The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2′,3′-dideoxycytidine, 2′,3′-dideoxy-3′-thiacytidine, and 2′,3′-dideoxyinosine shows reduced sensitivity to dideoxynucleoside triphosphate inhibitors in vitro. J. Biol. Chem. 262 1994 28118 28122
107. Z. Gu Q. Gao H. Fang H. Solomon M.A. Parniak Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2′,3′-dideoxycytidine and 2′,3′-dideoxy-3′-thiacytidine. Antimicrob. Agents Chemother. 38 1994 275 281
108. H. Guilley K.E. Richards G. Jonard Observations concerning the discontinuous DNAs of cauliflower mosaic virus. EMBO J. 7 1983 277 282
109. M. Hadzopoulos-Cladaras B. Felber C. Cladaras A. Athanassopoulos A. Tse The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J. Virol. 63 1989 1265 1274
110. S. Hallenberger V. Bosch H. Angliker E. Shaw H.-D. Klenk W. Garten Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp 160. Nature (London. 360 1992 358 361
111. J. Hansen T. Schulze K. Moelling RNase H activity associated with bacterially expressed reverse transcriptase of human T-cell lymphotropic virus III/lymphadenopathy-associated virus. J. Biol. Chem. 262 1987 12393 12396
112. J. Hansen T. Schulze W. Muller K. Moelling Identification and characterization of HIV-specific RNase H by monoclonal antibody. EMBO J. 7 1988 239 243
113. F. Harada R.C. Sawyer J.E. Dahlberg A primer ribonucleic acid for initiation in in vitro Rous sarcoma virus deoxyribonucleic acid synthesis. Nucleotide sequence and amino acid acceptor activity. J. Biol. Chem. 250 1975 3487 3497
114. W.A. Haseltine Molecular biology of the human immunodeficiency virus type 1. FASEB J. 5 1991 2349 2360
115. L.E. Henderson M.A. Bowers R.C. Sowder II S.A. Serabyn D.G. Johnson Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: Postranslational modifications, proteolytic processing, and complete amino acid sequences. J. Virol. 66 1992 1856 1865
116. A. Hizi R. Tal S.H. Hughes Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency type 2 reverse transcriptase expressed in Escherichia coli. Virology 180 1991 339 346
117. A. Hizi R. Tal M. Shaharbany M.J. Currens M.R. Boyd Specific inhibition of reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by non-nucleoside inhibitors. Antimicrob. Agents Chemother. 37 1993 1037 1042
118. Z. Hostomska D.A. Mathews J.F. Davies II B.F. Nodes Z. Hostomsky Proteolytic release and crystallization of the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem. 266 1991 14697 14702
119. Z. Hostomsky Z. Hostomska G.O. Hudson E.W. Moomaw B.R. Nodes Reconstitution in vitro of RNase H activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl. Acad. Sci. U.S.A. 88 1991 1148 1152
120. Z. Hostomsky G.O. Hudson S. Rahmati Z. Hostomska RNase D, a reported new activity associated with HIV-1 reverse transcriptase, display the same cleavage specificity as Escherichia coli RNase III. Nucleic Acids Res. 20 1992 5819 5824
121. J. Hotta P.C. Loh Enhanced production of a human spumavirus ( Retroviridae ) in semi-permissive cell cultures after treatment with 5′-azacytidine. J. Gen. Virol. 68 1987 1183 1186
122. K.J. Howard D.B. Frank I.S. Sim S.F.J. LeGrice Reconstitution and properties of homologous and chimeric HIV-1/HIV-2 p66/p51 reverse transcriptase. J. Biol. Chem. 266 1991 23003 23009
123. J.-C. Hsieh S. Zinnen P. Modrich Kinetic mechanism of DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase. J. Biol. Chem. 268 1993 24607 24613
124. W.-S. Hu H.M. Temin Retroviral recombination and reverse transcription. Scienc. 250 1990 1227 1233
125. Lys3 into human immunodeficiency virus type 1. J. Virol. 68 1994 7676 7683
126. H.E. Huber C.C. Richardson Processing of the primer for plus strand DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem. 265 1990 10565 10573
127. H.E. Huber J.M. Mc Coy J.S. Seehra C.C. Richardson Human immunodeficiency virus 1 reverse transcriptase: Template binding, processivity, strand displacement synthesis, and template switching. J. Biol. Chem. 264 1989 4669 4678
128. S.S. Hwang T.J. Boyle H.K. Lyerly B.R. Cullen Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Scienc. 253 1991 71 72
129. S. Inouye M.-Y. Hsu S. Angle M. Inouye Reverse transcriptase associated with the biosynthesis of the branched RNA-linked msDNA in Myxococcus xanthus. Cell (Cambridge, Mass.) 56 1989 709 717
130. Lys3 modulate primer/template loop–loop interaction in the initiation complex of HIV-1 reverse transcription. J. Biol. Chem. 268 1993 25269 25272
131. T. Jacks K. Townsley H.E. Varmus J. Majors Two efficient ribosomal frameshifting events are required for synthesis of mouse mammary tumor virus gag -related polyproteins. Proc. Natl. Acad. Sci. U.S.A. 84 1987 4298 4302
132. T. Jacks M.D. Power F.R. Masiarz P.A. Luciw P.J. Barr H.E. Varmus Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature (London) 331 1988 280 283
133. A. Jacobo-Molina E. Arnold HIV reverse transcriptase—function relationships. Biochemistr. 30 1991 6351 6361
134. A. Jacobo-Molina J. Ding R.G. Nanni A.D. Clark Jr. S. Lu Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl. Acad. Sci. U.S.A. 90 1993 6320 6324
135. P.S. Jacques B.M. Wohrl M. Ottman J.-L. Darlix F.J. Le Grice Mutating the “primer grip” of p66 HIV-1 reverse transcriptase implicates tryptophan 229 in template–primer utilization. J. Biol. Chem. 269 1994 2672 26478
136. P.S. Jacques B.M. Wöhrl K.J. Howard S.F.J. Le Grice Modulation of HIV-1 reverse transcriptase function in “selectively deleted” p66/p51 heterodimers. J. Biol. Chem. 269 1994 1388 1393
137. J. Ji J.-S. Hoffman L. Loeb Mutagenicity and pausing of HIV reverse transcriptase during HIV plus-strand DNA synthesis. Nucleic Acids Res. 22 1994 47 52
138. IIIB. Biochem. Biophys. Res. Commun. 185 1992 1005 1015
139. M. Jiang J. Mak A. Ladha E. Cohen M. Klein B. Rovinski L. Kleiman Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J. Virol. 67 1993 3246 3253
140. M.S. Johnson M.A. Mc Clure D.-F. Feng J. Gray R.F. Doolittle Computer analysis of retroviral pol genes: Assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes. Proc. Natl. Acad. Sci. U.S.A. 83 1986 7646 7652
141. H. Jonckheere J.-M. Taymans J. Balzarini S. Velazquez M.-J. Camarasa J. Desmyter E. De Clerq J. Anne Resistance of HIV-1 reverse transcriptase against [12′,5′-bis- O -( tert -butyldimethylsilyl)-3′-spiro-5”-(4′-amino-1,2”-oxathi-ole-2”,2”-dioxide)] (TSAO) derivatives by the muatation Glu-138 to Lys on the p51 subunit. J. Biol. Chem. 269 1994 26255 26258
142. S.-Y. Kao A.F. Calman P.A. Luciw B.M. Peterlin Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene production. Nature (London) 330 1987 489 493
143. F. Kashanchi G. Piras M.F. Radonovich J.F. Duvall A. Fattacy Direct interactions of huamn TFIID with HIV-1 transactivator tat. Nature (London) 367 1994 295 299
144. W.M. Kati K.A. Johnson L.F. Jerva K.S. Anderson Mechanism and fidelity of HIV reverse transcriptase. J. Biol. Chem. 267 1992 25988 25997
145. S. Kawa A. Kumar J.S. Smith S.P. Becerra W.A. Beard Expression and purification of the HIV-1 reverse transcriptase using the baculovirus expression vector system. Protein Expression Purif. 4 1993 298 303
146. R. Khan D.P. Giedroc Recombinant human immunodeficiency virus type 1 nucleocapsid (NCp7) protein unwinds tRNA. J. Biol. Chem. 267 1992 6689 6695
147. G.J. Klarmann C.A. Schauber B.D. Preston Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro. J. Biol. Chem. 268 1993 9793 9802
148. B. Klaver B. Berkhout Premature strand transfer by the HIV-1 reverse transcriptase during strong-stop DNA synthesis. Nucleic Acids Res. 22 1994 137 144
149. N.E. Kohl E.A. Emini W.A. Schleif L.J. Davis J.C. Heimbach Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. U.S.A. 85 1988 4686 4690
150. Gln2 as a primer in an in vitro primer-utilization assay. Proc. Natl. Acad. Sci. U.S.A. 89 1992 9652 9656
151. L.A. Kohlstaedt J. Wang J.M. Friedman P.A. Rice T.A. Steitz Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Scienc. 256 1992 1783 1790
152. R.A. Kroup V.J. Merluzzi K.D. Hargrave J. Adams K. Grozinger Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587. J. Infect. Dis. 163 1991 966 970
153. M.S. Krug S.L. Berger Ribonuclease H activities associated with reverse transcriptases are endonucleases. Proc. Natl. Acad. Sci. U.S.A. 86 1989 3539 3543
154. M. Kruhoffer C. Urbanke F. Grosse Two step binding of HIV-1 reverse transcriptase to nucleic acid substrates. Nucleic Acids Res. 21 1993 3943 3949
155. A. Kumar H.-R. Kim R.W. Sobol S.P. Becerra B.-J. Lee Mapping of nucleic acid binding in proteolytic domains of HIV-1 reverse transcriptase. Biochemistr. 32 1993 7466 7474
156. B.A. Kunz Mutagenesis and deoxyribonucleotide pool imbalances. Mutat. Res. 200 1988 133 147
157. S.F. Lacey B.A. Larder Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2′,3′-didehydro-2′,3′-dideoxythymidine. Antimicrob. Agents Chemother. 38 1994 1428 1432
158. B.A. Larder S.D. Kemp Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Scienc. 246 1989 1155 1158
159. B. Larder D. Purifoy K. Powell G. Darby AIDS virus reverse transcriptase defined by high level expression in Escherichia coli. EMBO J. 6 1987 3133 3137
160. B. Larder D.J.M. Purifoy K. Powell G. Darby Site-specific mutagenesis of AIDS virus reverse transcriptase. Nature (London. 327 1987 716 717
161. B.A. Larder G. Darby D.D. Richman HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Scienc. 243 1989 1731 1734
162. B.A. Larder S.D. Kemp D.J.M. Purifoy Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity. Proc. Natl. Acad. Sci. U.S.A. 86 1989 4803 4807
163. M.F. Laspia A.P. Rice M.B. Mathews HIV-1 tat protein increases transcriptional initiation and stabilizes elongation. Cell (Cambridge, Mass.) 59 1989 283 292
164. M. Laughrea L. Jetté A 19-nucleotide sequence upstream of the 5′ major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA. Biochemistr. 33 1994 13464 13474
165. gag precursor for incorporation of the vpr product into human immunodeficiency virus type 1 viral particles. J. Virol. 68 1994 1926 1934
166. H. Lederer O. Schatz R. May H. Crespi J.-L. Darlix Domain structure of the human immunodeficiency virus reverse transcriptase. EMBO J. 11 1992 1131 1139
167. S.F.J. Le Grice F. Gruninger-Leitch Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. Eur. J. Biochem. 187 1990 307 314
168. S.F.J. Le Grice V. Beuck J. Mous Expression of biologically active human T-cell lymphotropic virus type III reverse transcriptase in Bacillus subtilis. Gene 55 1987 95 103
169. S.F.J. Le Grice J. Mills J. Mous Active site mutagenesis of the AIDS virus proteaase and its alleviation by trans complementation. EMBO J. 7 1988 4686 4690
170. S.F.J. Le Grice J. Mills R. Ette J. Mous Comparison of the human immunodeficiency virus type 1 and 2 proteases by hybrid gene construction and transcomplementation. J. Biol. Chem. 264 1989 14902 14908
171. S.F.J. Le Grice T. Naas B. Wohlgensinger O. Schatz Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase. EMBO J. 10 1991 3905 3911
172. S.F.J. Le Grice M. Panin R.C. Kalayjian N.J. Richter G. Keith J.L. Darlix S.L. Payne Purification and characterization of recombinant equine infectious anemia virus reverse transcriptase. J. Virol. 65 1991 7004 7007
173. S.F.J. Le Grice C.E. Cameron S. Benkovic Purification of retroviral transcriptase. J.L. Campbell Methods in Enzymology 1994 Academic Press New York in press.
174. J. Leis J. Hurwitz RNA-dependent DNA polymerase activity of RNA tumor viruses. II. Directing influence of RNA in the reaction. J. Virol. 9 1972 130 142
175. J. Leis A. Aiyar D. Cobrinik Regulation of initiation of reverse transcription of retroviruses. A.M. Skalka S.P. Goff ‘Reverse Transcriptase’ 1993 Cold Spring Harbor Lboratory Cold Spring Harbor, New York 33 47
176. J.G. Levin J.G. Seidman Selective packaging of host tRNAs by murine leukemia virus particles does not require genomic RNA. J. Virol. 29 1979 328 335
177. J.G. Levin D.L. Hatfield S. Oroszlan A. Rein Mechanism of translational suppression used in the biosynthesis of reverse transcriptase. A.M. Skalka S.P. Goff ‘Reverse Transcriptase’ 1993 Cold Spring Harbor Laboratory Cold Spring Harbor, New York 5 31
178. W. Levinson J.M. Bishop N. Quintrell J. Jackson Presence of DNA in Rous sarcoma virus. Nature (London. 227 1970 1023 1025
179. P. Lewis M. Hensel M. Emerman Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 8 1992 3053 3058
180. X. Li J. Mak E.J. Arts L. Kleiman M.A. Wainberg M.A. Parniak Effects of alterations of primer binding site sequences on human immunodeficiency virus type 1 replication. J. Virol. 68 1994 6198 6206
181. gag nucleocapsid protein. Protein Expression Purif. 4 1993 304 311
182. M.M. Lightfoote J.E. Coligan T.M. Folks A.S. Fauci M.A. Martin S. Venkatesan Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome virus. J. Virol. 60 1986 771 775
183. F. Lori F. Di Marzo Veronese A.L. De Vico P. Lusso M.S. Reitz R.C. Gallo Viral DNA carried by human immunodeficiency virus type 1 virions. J. Virol. 66 1992 5067 5074
184. D.M. Lowe A. Aitkin C. Bradley G.K. Darby B.A. Larder HIV-1 reverse transcriptase: Crystallization and analysis of domain structure by limited proteolysis. Biochemistr. 27 1988 8884 8889
185. D.M. Lowe V. Parmor S.D. Kemp B.A. Larder Mutational analysis of two conserved sequence motifs in HIV-1 reverse transcriptase. FEBS Lett. 282 1991 231 234
186. S. Loya R. Tal S.H. Hughes A. Hizi The effects of cysteine mutations on the catalytic activities of the reverse transcriptase of human immunodeficiency virus type-1. J. Biol. Chem. 267 1992 13879 13883
187. G.X. Luo J. Taylor Template switching by reverse transcriptase during DNA synthesis. J. Virol. 64 1990 4321 4328
188. G. Luo L. Sharmeen J. Taylor Specificities involved in the initiation of retroviral plus-strand DNA. J. Virol. 64 1990 592 597
189. + cells by a complex of a 110K viral protein and the T4 molecule. Science 231 1986 382 385
190. P.J. Maddon A.G. Dalgleish J.S. Mc Dougal P.R. Clapham R.A. Weiss R. Axel The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell (Cambridge, Mass.) 47 1986 333 348
191. C. Majumdar J. Abbotts S. Broder S.H. Wilson Studies on the mechanism of human immunodeficiency virus reverse transcriptase: Steady-state kinetics, processivity, and polynucleotide inhibition. J. Biol. Chem. 263 1988 15657 15665
192. Lys into human immunodeficiency virus type 1 particles. J. Virol. 68 1994 2065 2072
193. M.H. Malim J. Hauber S.-Y. Le J.V. Maizel B.R. Cullen The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (London) 338 1989 254 257
194. J.L. Martin J.E. Wilson E.S. Furfine S.E. Hopkins P.A. Furman Biochemical analysis of human immunodeficiency virus-1 reverse transcriptase containing a mutation at position lysine 263. J. Biol. Chem. 268 1993 2565 2570
195. J.L. Martin J.E. Wilson R.L. Haynes P.A. Furman Mechanism of resistance of human immunodeficiency virus type 1 to 2′,3′-dideoxyinosine. Proc. Natl. Acad. Sci. U.S.A. 90 1993 6135 6139
196. H. Masur M.A. Michelis J.B. Greene I. Onovato R.A. van De Stowe An outbreak of community-acquired pneumocystis carinii pneumonia: Initial manifestation of cellular immune dysfunction. N. Engl. J. Med. 305 1981 1431 1438
197. C. Meric S. Goff Characterization of Moloney murine leukemia virus mutants with single amino acid substitutions in the Cys–His box of the NC protein. J. Virol. 63 1989 1558 1568
198. W. Metzger T. Herman O. Schatz S.F.J. Le Grice H. Hermann Hydroxyl radical footprint analysis of human immunodeficiency virus reverse transcriptase-template/primer complexes. Proc. Natl. Acad. Sci. U.S.A. 90 1993 5909 5913
199. H. Mitsuya K.J. Weinhold P.A. Furman M.H. St. Clair S.N. Lehrman 3′-Azido-3′-deoxythymidine (BWA509V): An antiviral agent that inhibits the infectivity and cytopathic effects of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. U.S.A. 82 1985 7096 7100
200. V. Mizrahi G.M. Lazarus L.M. Miles C.A. Myers C. Debouck Recombinant HIV-1 reverse transcriptase: Purification, primary structure, and polymerase/ribonuclease H activities. Arch. Biochem. Biophys. 273 1989 347 358
201. V. Mizrahi R.L. Brooksbank N.C. Nkabinde Mutagenesis of the conserved aspartic acid 443, glutamic acid 478, asparagine 494, and aspartic acid 498 residues in the ribonuclease H domain of p66/p51 human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem. 269 1994 19245 19249
202. K. Mölling D.P. Bolognesi H. Bauser W. Büssen H.W. Plassmann P. Hausen Association of viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA–DNA hybrids. Nature (London. 234 1971 240 243
203. J. Mous E.P. Heimer S.F.J. Le Grice Processing protease and reverse transcriptase from human immunodeficiency type 1 polyprotein in Escherichia coli. J. Virol. 62 1988 1433 1436
204. J.E. Murphy S.P. Goff Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: Effects on RNA packaging and reverse transcription. J. Virol. 63 1989 319 327
205. T. Nagashunmugam A. Velpandi C.S. Goldsmith S.R. Zaki V.S. Kalyanaraman A. Srinivasan Mutation in the primer binding site of the type 1 human immunodeficiency virus genome affects virus production and infectivity. Proc. Natl. Acad. Sci. U.S.A. 89 1992 4114 4118
206. R.G. Nanni J. Ding A. Jacobo-Molina S.H. Hughes E. Arnold Review of HIV-1 reverse transcriptase three-dimensional structure: Implications for drug design. Perspect. Drug Discovery Des. 1 1993 129 150
207. D. Ollis P. Brick R. Hamlin N.G. Xuong T.A. Steitz Structure of large fragment of Escherichia coli DNA polymerase I complexed with dTMP. Nature (London) 313 1985 762 766
208. C.A. Omer R. Resnick A.J. Faras Evidence for involvement of an RNA primer in initiation of strong-stop plus DNA synthesis during reverse transcription in vitro. J. Virol. 50 1984 465 470
209. M. Ouhammouch E.N. Brody Temperature-dependent template switching during in vitro cDNA synthesis by the AMV-reverse transcriptase. Nucleic Acids Res. 20 1992 5443 5450
210. F.R. Oyama R. Kikuchi R.J. Crouch T. Uchida Intrinsic properties of reverse transcriptase in reverse transcription. Associated RNase H is essentially regarded as an endonuclease. J. Biol. Chem. 264 1989 18808 18817
211. J.-C. Paillart R. Marquet E. Skripkin B. Ehresmann C. Ehresmann Mutational analysis of the bipartite dimer linkage structure of human immunodeficiency virus type 1 genomic RNA. J. Biol. Chem. 269 1994 27486 27493
212. G.R. Painter L.L. Wright S. Hopkins P.A. Furman Initial binding of 2′-deoxynucleoside 5′-triphosphates to human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem. 266 1991 19362 19368
213. G.R. Painter A.E. Aulabaugh C.W. Andrews A comparison of the conformations of the 5′-triphosphates of zidovudine (AZT) and thymidine bound to HIV-1 reverse transcriptase. Biochem. Biophys. Res. Commun. 191 1993 1166 1171
214. Trp to avian myeloblastosis virus RNA-dependent DNA polymerase. Proc. Natl. Acad. Sci. U.S.A. 72 1975 2535 2539
215. A.T. Paganiban D. Fiore Ordered interstrand and intrastrand DNA transfer during reverse transcription. Scienc. 241 1988 1064 1069
216. gag and is incorporated into viruslike particles. J. Virol. 66 1992 6304 6314
217. N.T. Parkin M. Chamorro H.E. Varmus Human immunodeficiency virus type 1 gag-pol frameshifting is dependent on downstream messenger RNA secondary structure: Demonstration by expression in vivo. J. Virol. 66 1992 5147 5151
218. J.A. Peliska S.J. Benkovic Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Scienc. 258 1992 1112 1118
219. J.A. Peliska S. Balasubranmanian D.P. Giedroc S.J. Benkovic Recombinant HIV-1 nucleocapsid protein accelerates HIV-1 reverse transcriptase catalyzed DNA strand transfer reactions and modulates RNase H activity. Biochemistr. 33 1994 13817 13823
220. H. Pelletier M.R. Sawaya A. Kumar S.H. Wilson J. Kraut Structures of ternary complexes of rat DNA polymerase β, a DNA template-primer, and ddCTP. Scienc. 264 1994 1891 1903
221. C. Peng B.K. Ho T.W. Chang N.T. Chang Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. J. Virol. 63 1989 2550 2556
222. C. Peng N.T. Cheng T.W. Chang Identification and characterization of human immunodeficiency virus type 1 gag-pol fusion protein in transfected mammalian cells. J. Virol. 63 1991 2550 2556
223. G.G. Peters J. Hu Reverse transcriptase as the major determinant for selective packaging of tRNAs into avian sarcoma virus particles. J. Virol. 26 1980 962 700
224. G. Peters F. Harada J.E. Dahlberg A. Panet W.A. Haseltine D. Baltimore Low-molecular-weight RNAs of Moloney murine leukemia virus: Identification of the primer for RNA-directed DNA synthesis. J. Virol. 21 1977 1031 1041
225. P. Pfeiffer T. Hohn Involvement of reverse transcription in the replication of cauliflower mosaic virus: A detailed model and test of some aspects. Cell 33 (Cambridge, Mass.) 33 1983 781 789
226. G. Phear J. Nalbantoglu M. Meuth Next nucleotide effects in mutation driven by DNA precursor pool imbalances at the aprt locus of Chinese hamster ovary cells. Proc. Natl. Acad. Sci. U.S.A. 84 1987 3465 3469
227. A.H. Polesky T.A. Steitz N.D.F. Grindle C.W. Joyce Identification of residues critical for the polymerase activity of the Klenow fragment of DNA polymerase I from Escherichia coli. J. Biol Chem. 265 1990 14579 14591
228. A.H. Polesky M. Dahlberg S.J. Benkovic N.D. Grindley C.W. Joyce Side chains involved in catalysis of the polymerase reaction of DNA polymerase I from Escherichia coli. J. Biol Chem. 267 1992 8417 8428
229. R.J. Pomerantz D. Trono M.B. Feinberg D. Baltimore Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency. Cell (Cambridge, Mass.) 61 1990 1271 1276
230. M. Popovic M.G. Sarngadharan E. Read R.C. Gallo Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Scienc. 224 1984 497 500
231. K. Post J. Guo E. Kalman T. Uchida R.J. Crouch J.G. Levin A large deletion in the connection subdomain of murine leukemia virus reverse transcriptase or replacement of the RNase H domain with Escherichia coli RNase H results in alterred polymerase and RNase H activities. Biochemistry 32 1993 5508 5517
232. 15N relaxation measurements. Biochemistry 31 1992 9150 9157
233. V.R. Prasad S.P. Goff A novel in situ colony screening method to detect immunodeficiency virus reverse transcriptase activity in bacteria. J. Biol. Chem. 264 1989 16689 16693
234. V.R. Prasad S.P. Goff Linker insertion mutagensis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: Definition of the minimal polymerase domain. Proc. Natl. Acad. Sci. U.S.A. 86 1989 3104 3108
235. B.D. Preston B.J. Poiesz L.A. Loeb Fidelity of HIV-1 reverse transcriptase. Scienc. 242 1988 1168 1171
236. K.A. Pullen A.J. Rattray J.J. Champoux The sequence features important for plus strand priming by human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem. 268 1993 6221 6227
237. L. Ratner W. Haseltine R. Patarca K.J. Litvak B. Starcich Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (London. 313 1985 277 284
238. J.E. Reardon Human immunodeficiency virus reverse transcriptase: A kinetic analysis of RNA-dependent and DNA-dependent DNA polymerization. J. Biol. Chem. 268 1993 8743 8751
239. R. Resnick C.A. Omer A.J. Faras Involvement of retrovirus reverse transcriptase-associated RNase H in the initiation of strong-stop (+) DNA synthesis and the generation of the long terminal repeat. J. Virol. 51 1984 813 821
240. T. Restle B. Muller R.S. Goody Dimerization of human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem. 265 1990 8986 8988
241. Lys3 primer-binding site of human immunodeficiency virus type 1 identified essential regions for reverse transcription. J. Virol. 65 1991 4555 4564
242. M. Ricchetti H. Buc Reverse transcriptase and genomic variability: The accuracy of DNA replication is enzyme specific and sequence dependent. EMBO J. 9 1990 1583 1593
243. Lys3 with multiple forms of human immunodeficiency virus reverse transcriptase. J. Biol. Chem. 267 1992 15952 15957
244. Lys induce important structural changes in human immunodeficiency virus reverse transcription. FEBS Lett. 277 1990 239 242
245. J.D. Roberts K. Bebenek T.A. Kunkel The accuracy of reverse transcriptase from HIV-1. Scienc. 242 1988 1171 1173
246. T.-Y. Roe T.C. Reynolds G. Yu P.O. Brown Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12 1993 2099 2108
247. M. Roth N. Tanese S.P. Goff Purification and characterization of murine retroviral reverse transcriptase expressed in E. coli. J. Biol. Chem. 290 1985 9326 9335
248. M.J. Roth P.L. Schwartzberg S.P. Goff Structure of the termini of DNA intermediates in the integration of retroviral DNA: Dependence on IN function and terminal DNA sequence. Cell (Cambridge, Mass.) 58 1989 47 54
249. M.H. St. Clair J.L. Martin G. Tudor-Williams M.L. Bach C.L. Vavro D.M. King P. Kellam S.D. Kemp B.A. Larder Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 253 1991 1557 1559
250. K. Sakaguchi N. Zambrano E.T. Baldwin B.A. Shapiro J.W. Erickson Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein. Proc. Natl. Acad. Sci. U.S.A. 90 1993 5219 5223
251. H. Sakai R. Shibata J. Sakuragi S. Sakuragi M. Kawamura A. Adachi Cell-dependent requirement of human immunodeficiency virus type 1 vif protein for maturation of virus particles. J. Virol. 67 1993 1663 1666
252. K. Sakai X.Y. Ma I. Gordienko D.J. Volsky Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: Role of the vif gene in HIV-1 infection kinetics and cytopathicity J. Virol 65 1991 5765 5773
253. Lys as evidenced by footprinting studies and inhibition with synthetic oligoribonucleotides. J. Mol. Biol. 226 1992 1 6
254. M.R. Sawaya H. Pelletier A. Kumar S.H. Wilson J. Kraut Crystal structure of rat DNA polymerase β: Evidence for a common polymerase mechanism. Scienc. 264 1994 1930 1935
255. O. Schatz F.V. Cromme F. Gruninger-Leitch S.F.J. Le Grice Point mutations in conserved amino acid residues within the C-terminal domain of HIV-1 reverse transcriptase specifically repress RNase H function. FEBS Lett. 257 1989 311 314
256. O. Schatz J. Mous S.F.J. Le Grice HIV-1 RT-associated ribonuclease H displays both endonuclease and 3′-5′ exonuclease activity. EMBO J. 9 1990 1171 1176
257. R.F. Schinazi R.M. Lloyd M.-H. Nguyen D.L. Cannon A. Mc Millan Characterization of human immunodeficiency viruses resistant to oxathiolanecytosine nucleosides. Antimicrob. Agents Chemother. 37 1993 875 881
258. T.M. Schinnich R.A. Lerner J.G. Sutcliffe Nucleotide sequence of Moloney murine leukemia virus. Nature (London. 293 1981 543 548
259. J. Schneider O. Kaaden T.D. Copeland S. Oroszlan G. Hunsmann Shedding and interspecies type seroreactivity of the envelope gp 120 of the human immunodeficiency virus. J. Gen. Virol. 67 1986 25331 22538
260. S.C. Schultz G.C. Schields T.A. Steitz Crystal structure of a CAP-DNA complex: The DNA is bent by 90 degrees. Scienc. 253 1991 1001 1007
261. E. Selsing R.D. Wells C.J. Alden S. Arnott Bent DNA: Visualization of a base-paired and stacked A-B conformation junction. J. Biol. Chem. 254 1979 5417 5422
262. M. Shaharabany A. Hizi The catalytic functions of chimeric reverse transcriptase of human immunodeficiency viruses type 1 and 2. J. Biol. Chem. 267 1992 3674 3678
263. S.K. Sharma N. Fan D.B. Evans Human immunodeficiency virus type 1 (HIV-1) recombinant reverse transcriptase. Asymmetry in p66 subunits of the p66/p66 homodimer. FEBS Lett. 343 1994 125 130
264. P.A. Sharp R.A. Mariniak HIV TAR: An RNA enhancer? Cell (Cambridge, Mass.) 59 1989 229 230
265. C.K. Shih J.M. Rose G.L. Hansen J.C. Wu A. Bacolla J.A. Griffin Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptase displays altered sensitivity to nonnucleoside analog inhibitors. Proc. Natl. Acad. Sci. U.S.A. 88 1991 9878 9882
266. A.M. Skalka S.P. Goff ‘Reverse Transcriptase.’ 1993 Cold Spring Harbor Laboratory Cold Spring Harbor, New York
267. S.J. Smerdon J. Jager J. Wang L.A. Kohlstaedt A.J. Chirino J.M. Friedman P.A. Rice T.A. Steitz Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 91 1994 3911 3915
268. gag-pol from human immunodeficiency virus type 1 into virus-like particles. J. Virol. 67 1993 2266 2275
269. J.K. Smith A. Cywinski J.M. Taylor Initiation of plus-strand DNA synthesis during reverse transcription of an avian retrovirus genome. J. Virol. 49 1984 200 204
270. J.K. Smith A. Cywinski J.M. Taylor Specificity of initiation of plusstrand DNA by Rous sarcoma virus. J. Virol. 52 1984 314 319
271. Lys3. J. Biol. Chem. 267 1992 15071 15079
272. J.S. Smith M.J. Roth Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain. J. Virol. 67 1993 4037 4049
273. J.S. Smith K. Gritsman M.J. Roth Contributions of DNA polymerase subdomains to the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem. 68 1994 5721 5729
274. R.W. Sobol R.J. Suhadolnik A. Kumar B.J. Lee D.L. Hatfield S.H. Wilson Localization of a polynucleotide binding region in the HIV-1 reverse transcriptase: Implications for primer binding. Biochemistr. 30 1991 10623 10631
275. J. Sodroski C.A. Rosen W.A. Haseltine Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Scienc. 225 1984 381 421
276. J. Sodroski W.C. Goh C. Rosen A. Dayton E. Terwilliger Haseltine A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature (London. 321 1986 412 417
277. D.A. Soltis A.M. Skalka The α and β chains of avian retrovirus reverse transcriptase independently expressed in Escherichia coli: Characterization of enzymatic activities. Proc. Natl. Acad. Sci. U.S.A. 85 1988 3372 3376
278. J. Sorge S.H. Hughes Polypurine tract adjacent to the U3 region of the Rous sarcoma virus genome provides a cis-acting function. J. Virol. 43 1982 482 488
279. T.L. South P.R. Blake R.C. Sowder III L.O. Arthur L.E. Henderson M.F. Summers The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers. Biochemistr. 29 1990 7786 7789
280. M.C. Starnes Y.-C. Cheng Human immunodeficiency virus reverse transcriptase-associated RNase H activity. J. Biol. Chem. 264 1989 7073 7077
281. B.S. Stein S.D. Gouda J.D. Lifson R.C. Penhallow K.G. Bensch E.G. Engleman PH- Independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell (Cambridge, Mass.) 49 1987 659 668
282. M. Stevenson T.L. Stanwick M.P. Dempsey C.A. Lamonica HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9 1990 1551 1560
283. G. Streisinger Y. Okada J. Emrich J. Newton A. Tsugita Frameshift mutations and the genetic code. Cold Spring Harbor Symp. Quant. Biol. 31 1966 77 84
284. J. Summers W.S. Mason Replication of the genome of an hepatitis-B like virus by reverse transcription of an RNA intermediate. Cell (Cambridge, Mass.) 29 1982 403 415
285. J.L. Susman S.-H. Kim Three-dimensional structure of a transfer RNA in two crystal forms. Scienc. 192 1976 853 858
286. R. Swanstrom J.M. Bishop H.E. Varmus Structure of a replication intermediate in the synthesis of Rous sarcoma virus DNA in vivo. J. Virol. 42 1982 337 341
287. Y. Takeuchi T. Nagumo H. Hoshino Low fidelity of cell-free DNA synthesis by reverse transcriptase of human immunodeficiency virus. J. Virol. 62 1988 3900 3902
288. N. Tanese J. Sodroski W.A. Hazeltine S.P. Goff Expression of reverse transcriptase activity of human T-lymphotropic virus type III (HTLV-III/LAV) in Escherichia coli. J. Virol. 59 1986 743 745
289. J.M. Taylor R. Illmensee Site on the RNA of an avian sarcoma virus at which primer is bound. J. Virol. 16 1975 553 558
290. A. Telesnitsky S.P. Goff Strong-stop strand transfer during reverse transcription. A.M. Skalka S.P. Goff ‘Reverse Transcriptase’ 1993 Cold Spring Harbor Laboratory Cold Spring Harbor, New York 49 83
291. A. Telesnitsky S.P. Goff RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template. Proc. Natl. Acad. Sci. U.S.A. 90 1993 1276 1280
292. H.M. Temin Reverse transcription in the eukaryotic genome: Retroviruses, pararetroviruses, retrotransposons, and retrotranscripts. Mol. Biol. Evol. 2 1985 455 468
293. H. Temin S. Mizutani RNA-directed DNA polymerase in virions of Rous sarcoma virus. Nature (London. 226 1970 1211 1213
294. D.S. Threadgill W.K. Steagall N.T. Flaherty F.J. Fuller S.T. Perry Characterization of equine infectious anemia virus UTPase: Growth properties of a dUTPase-deficient mutant. J. Virol. 67 1993 2592 2600
295. M. Tisdale P. Erlt B.A. Larder D.J.M. Purifoy G. Darby K. Powell Characterization of human immunodeficiency virus type 1 reverse transcriptase by using monoclonal antibodies: Role of the C-terminus in antibody reactivity and enzyme function. J. Virol. 62 1988 3662 3667
296. M. Tisdale T. Schulze B.A. Larder K. Moelling Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity. J. Gen. Virol. 72 1991 59 66
297. P. Trono Partial reverse transcription in virions from human immunodeficiency and murine leukemia virus. J. Virol. 66 1992 4893 4900
298. Z. Tsuchihashi P.O. Brown DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 68 1994 5863 5870
299. J.P. Vartanian A. Meyerans M. Sala S. Wain-Hobson G to A hypermutation of the human immunodeficiency virus type 1 genome: Evidence for dCTP pool imbalance during reverse transcription. Proc. Natl. Acad. Sci. U.S.A. 91 1994 3092 3096
300. I.M. Verma N.L. Meuth E. Bromfeld K.F. Manly D. Baltimore Covalently linked RNA-DNA molecule as initial product of RNA tumor virus DNA polymerase. Nature (London. 233 1971 131 134
301. gag-polyprotein essential for HIV-1 particle formation. Virology 193 1993 981 985
302. J.K. Wakefield S.A. Jablonski C.D. Morrow In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome. J. Virol. 66 1992 6806 6812
303. J.K. Wakefield H. Rhim C.D. Morrow Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site. J. Virol. 68 1994 1605 1614
304. C.T. Wang Y. Zhang J. Mc Dermott E. Barklis Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. J. Virol. 67 1993 7067 7076
305. J. Wang S.J. Smerdon J. Jager L.A. Kohlstaedt P.A. Rice J.M. Friedman T.A. Steitz Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer. Proc. Natl. Acad. Sci. U.S.A. 91 1994 7242 7246
306. L.C. Waters B.C. Mullin Transfer RNA in RNA tumor viruses. Prog. Nucleic Acid Res. Mol. Biol. 20 1977 131 160
307. R. Weiss N. Teich H. Varmus J. Coffin ‘RNA Tumor Viruses.’ 1985 Cold Spring Harbor Laboratory Cold Spring Harbor, New York
308. A.B. West T.M. Roberts R.D. Kolodner Regulation of the reverse transcriptase of human immunodeficiency virus type 1 by dNTPs. Proc. Natl. Acad. Sci. U.S.A. 89 1992 9720 9724
309. J.M. Whitcomb R. Kumar S.H. Hughes Sequence of the circle junction of human immunodeficiency virus type 1: Implications for reverse transcription and integration. J. Virol. 64 1990 4903 4906
310. S.H. Whiting J.J. Champoux Strand displacement synthesis capability of Moloney murine leukemia virus reverse transcriptase. J. Virol. 68 1994 4747 4758
311. K.J. Williams L.A. Loeb Retroviral reverse transcriptases error frequencies and mutagenesis. Curr. Top. Microb. Immunol. 176 1992 165 180
312. B.J. Winslow R.J. Pomerantz O. Bagasra D. Trono HIV-1 latency due to the site of proviral integration. Virolog. 196 1993 849 854
313. B.M. Wöhrl S. Volkmann K. Moelling Mutations of a conserved residue within HIV-1 ribonuclease H affect its exo- and endonuclease activities. J. Mol. Biol. 220 1991 801 818
314. Lys3 complexes. J. Biol. Chem. 268 1993 13617 13624
315. B.M. Wöhrl K.J. Howard P.S. Jacques S.F.J. Le Grice Alternative modes of polymerization distinguish the subunits of equine infectious anemia virus reverse transcriptase. J. Biol. Chem. 269 1994 8541 8548
316. B.M. Wöhrl M.M. Georgiadis A. Telesnitsky W.A. Hendrickson S.F.J. Le Grice Footprinting analysis of replicating murine leukemia virus reverse transcriptase. Scienc. 267 1995 96 99
317. B.M. Wöhrl C. Tantillo E. Arnold S.F.J. Le Grice An expanded model of replicating human immunodeficiency virus reverse transcriptase. Biochemistry 1995 34 in press.
318. S.F. Wong A.F. Wahl P.-M. Yuan N. Arai B.E. Pearson Human polymerase α gene expression is cell proliferation dependent and its primary structure is similar to both prokaryotic and eukaryotic replicative DNA polymerases. EMBO J. 7 1988 37 44
319. F. Wong-Staal R.C. Gallo Human T-lymphotropic retroviruses. Nature (London. 317 1985 395 403
320. J. Wu E. Amandoron X. Li M.A. Wainberg M.A. Parniak Monoclonal antibody-mediated inhibition of HIV-1 reverse transcriptase polymerase activity. J. Biol. Chem. 268 1993 9980 9985
321. Y. Xiong T.J. Eickbush Origin and evolution of retroelements based upon their reverse transcriptase sequences. EMBO J. 9 1990 3353 3362
322. W. Yang W.A. Hendrickson R.J. Crouch Y. Satow Structure of ribonuclease H phased at 2 Å resolution by MAD analysis of the selenomethionyl protein. Scienc. 249 1990 1398 1405
323. G. Yu M. Salazar B.R. Reid Structure of a DNA:RNA hybrid duplex. J. Mol. Biol. 233 1993 509 523
324. H. Yu M.F. Goodman Comparison of HIV-1 and avian myeloblastosis virus reverse transcriptase fidelity on RNA and DNA templates. J. Biol. Chem. 267 1992 10888 10896
325. X. Yu X. Yuan Z. Matsuda T.H. Lee M. Essex The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66 1992 4966 4971
326. X. Yuan X. Yu T.H. Lee M. Essex Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the gag precusor. J. Virol. 67 1993 6387 6394
327. J.A. Zack S.J. Arrigo S.R. Weitman A.S. Go A. Haislip I.S.Y. Chen HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell (Cambridge, Mass.) 61 1990 213 222
328. J.A. Zack A.M. Haislip P. Krogstad I.S. Chen Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66 1992 1717 1725
329. D. Zhang A.M. Caliendo J.J. Eron K.M. De Vore J.C. Kaplan M.S. Hirsch R.T. D'Aquila Resistance to 2′,3′-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase. Anti-microb. Agents Chemother. 38 1994 282 287
330. H. Zhang Y. Zhang T.P. Spicer L.Z. Abbott B.J. Poiesz Reverse transcription takes place within extracellular HIV-1 virions: Potential biological significance. AIDS Res. Hum. Retroviruse. 9 1993 1287 1296
331. H. Zhang O. Bagasra M. Niikura B.J. Poiesz R.J. Pomerantz Intravirion reverse transcripts in the peripheral blood plasma of human immunodeficiency virus type 1-infected individuals. J. Virol. 68 1994 7591 7597
332. H. Zucher B. Steigler Optimal computer folding of large RNA sequences using thermodynamics and auxillary information. Nucleic Acids Res. 18 1981 1839 1846
333. G. Zybarth H.G. Krausslich K. Partin C. Carter Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain. J. Virol. 68 1994 240 250